Omnicell, Inc. (NASDAQ:OMCL) had its price target increased by Craig Hallum from $46.00 to $52.00 in a research report sent to investors on Friday, The Fly reports. Craig Hallum currently has a buy rating on the stock.

Several other research analysts have also recently issued reports on OMCL. Zacks Investment Research upgraded shares of Omnicell from a sell rating to a hold rating in a report on Tuesday, July 4th. CIBC increased their price target on shares of Omnicell from $43.00 to $53.00 and gave the stock an outperform rating in a research note on Wednesday, April 26th. TheStreet cut shares of Omnicell from a b- rating to a c+ rating in a research note on Thursday, May 4th. Piper Jaffray Companies cut shares of Omnicell from an overweight rating to a neutral rating and set a $40.00 price target for the company. in a research note on Friday, April 21st. Finally, Oppenheimer Holdings, Inc. reiterated an outperform rating and set a $53.00 price target (up previously from $43.00) on shares of Omnicell in a research note on Tuesday, April 25th. Four research analysts have rated the stock with a hold rating and seven have issued a buy rating to the company. The company currently has a consensus rating of Buy and an average price target of $49.00.

Shares of Omnicell (OMCL) traded down 0.20% during midday trading on Friday, reaching $49.50. 58,660 shares of the company’s stock traded hands. Omnicell has a 1-year low of $30.35 and a 1-year high of $49.90. The stock’s market capitalization is $1.84 billion. The firm’s 50-day moving average price is $43.49 and its 200 day moving average price is $40.22.

Omnicell (NASDAQ:OMCL) last posted its quarterly earnings results on Thursday, July 27th. The company reported $0.02 EPS for the quarter, hitting the consensus estimate of $0.02. Omnicell had a negative net margin of 1.14% and a positive return on equity of 0.41%. The company had revenue of $180.90 million during the quarter, compared to analysts’ expectations of $174.08 million. During the same quarter in the previous year, the business posted $0.38 EPS. The firm’s revenue was up 4.6% on a year-over-year basis. On average, equities analysts predict that Omnicell will post $1.28 earnings per share for the current fiscal year.

COPYRIGHT VIOLATION WARNING: “Omnicell, Inc. (OMCL) PT Raised to $52.00” was first reported by Watch List News and is the sole property of of Watch List News. If you are viewing this piece on another website, it was stolen and reposted in violation of US and international copyright legislation. The legal version of this piece can be accessed at https://www.watchlistnews.com/omnicell-inc-omcl-pt-raised-to-52-00/1465747.html.

In other news, Chairman Randall A. Lipps sold 37,500 shares of the stock in a transaction dated Friday, July 28th. The shares were sold at an average price of $46.00, for a total value of $1,725,000.00. Following the completion of the transaction, the chairman now owns 196,551 shares in the company, valued at approximately $9,041,346. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Chairman Randall A. Lipps sold 9,900 shares of the stock in a transaction dated Monday, June 5th. The shares were sold at an average price of $43.00, for a total transaction of $425,700.00. Following the completion of the transaction, the chairman now owns 208,982 shares of the company’s stock, valued at approximately $8,986,226. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 120,300 shares of company stock valued at $5,199,801. 3.77% of the stock is owned by insiders.

Several institutional investors have recently made changes to their positions in OMCL. Monroe Bank & Trust MI increased its stake in shares of Omnicell by 0.3% in the first quarter. Monroe Bank & Trust MI now owns 34,831 shares of the company’s stock worth $1,416,000 after buying an additional 116 shares during the period. State of Alaska Department of Revenue increased its stake in shares of Omnicell by 3.0% in the first quarter. State of Alaska Department of Revenue now owns 4,080 shares of the company’s stock worth $165,000 after buying an additional 120 shares during the period. Texas Permanent School Fund increased its stake in shares of Omnicell by 0.5% in the first quarter. Texas Permanent School Fund now owns 26,756 shares of the company’s stock worth $1,088,000 after buying an additional 122 shares during the period. Municipal Employees Retirement System of Michigan increased its stake in shares of Omnicell by 2.6% in the first quarter. Municipal Employees Retirement System of Michigan now owns 8,340 shares of the company’s stock worth $339,000 after buying an additional 210 shares during the period. Finally, 1st Global Advisors Inc. increased its stake in shares of Omnicell by 3.4% in the first quarter. 1st Global Advisors Inc. now owns 7,828 shares of the company’s stock worth $318,000 after buying an additional 255 shares during the period. Institutional investors and hedge funds own 96.35% of the company’s stock.

Omnicell Company Profile

Omnicell, Inc provides automation and business analytics software solutions for patient-centric medication and supply management across the entire healthcare continuum, from the acute care hospital setting to post-acute skilled nursing and long-term care facilities to the home. It operates through two segments: Automation and Analytics, and Medication Adherence.

The Fly

Analyst Recommendations for Omnicell (NASDAQ:OMCL)

Receive News & Ratings for Omnicell Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Omnicell Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.